South Korea exported $21 million worth of chicken last year, up 59.5 percent from a year earlier, due to the growing demand for ready-to-eat products and the Korean pop culture's popularity.
According to the report from the Korea International Trade Association (KITA), the increase was a result of the popularity of packaged traditional chicken soup, or "samgyetang," and chicken breast spiked due to demand for home meal replacements and the overseas popularity of Korean music, and movies.
South Korea exported the highest volume of chicken last year to the US, reaching $5.9 million, or 28.1 percent of the total.
The country's processed chicken accounted for 2.1 percent of US chicken imports last year, up from 0.9 percent in 2016.
Hong Kong was second with $4.96 million worth, representing a 162.4 percent increase from 2019.
An artificial intelligence analysis identified Hong Kong as the overseas market with the greatest potential, followed by Japan and the US.


China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 



